Form 4: Lemaitre Vascular Director Roush Acquires Dividend Equivalent Rights

Director John A. Roush acquired dividend equivalent rights related to restricted stock unit and performance share unit awards.

Summary

• John A. Roush, a director of Lemaitre Vascular Inc., acquired dividend equivalent rights on May 30, 2024.
• These rights are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
• The acquisitions include 0.402 rights related to a 2021 RSU award, 0.8146 rights related to a 2022 RSU award, 0.8146 rights related to a 2022 PSU award, and 1.0426 rights related to a 2023 RSU award.
• Each dividend equivalent right is the economic equivalent of one share of Lemaitre Vascular's common stock and vests proportionately with the underlying award.
• The reported transactions did not involve a purchase price as they are dividend equivalent rights.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative.

Positives

• The acquisition of dividend equivalent rights suggests continued alignment of the director's interests with those of shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The acquisition of dividend equivalent rights is a common practice for equity-based compensation.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minor positive impact on stakeholders as it aligns the director's interests with those of shareholders.

Key Dates